Article
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Haematologica - 1 Dec 2021
Sargas Claudia, Ayala Rosa, Chillón María Carmen, Larráyoz María J, Carrillo-Cruz Estrella, Bilbao Cristina, Yébenes-Ramírez Manuel, Llop Marta, Rapado Inmaculada, García-Sanz Ramón, Vázquez Iria, Soria Elena, Florido-Ortega Yanira, Janusz Kamila, Botella Carmen, Serrano Josefina, Martínez-Cuadrón David, Bergua Juan, Amigo Mari Luz, Martínez-Sánchez Pilar, Tormo Mar, Bernal Teresa, Herrera-Puente Pilar, García Raimundo, Algarra Lorenzo, Sayas María J, Costilla-Barriga Lisette, Pérez-Santolalla Esther, Marchante Inmaculada, Lavilla-Rubira Esperanza, Noriega Víctor, Alonso-Domínguez Juan M, Sanz Miguel Á, Sánchez-Garcia Joaquín, Gómez-Casares María T, Pérez-Simón José A, Calasanz María J, González-Díaz Marcos, Martínez-López Joaquín, Barragán Eva, Montesinos Pau
Abstract excerpt
Next-Generation Sequencing has recently been introduced to efficiently and simultaneously detect genetic variations in acute myeloid leukemia. However, its implementation in the clinical routine raises new challenges focused on the diversity of assays and variant reporting criteria. To overcome this challenge, the PETHEMA group established a nationwide network of reference laboratories aimed to deliver molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.